Septerna Inc
NASDAQ:SEPN
Septerna Inc
NASDAQ:SEPN
Price:
28.81
USD
-0.86%
Market Cap:
$1.3B
Relative Value
The Relative Value of one
SEPN
stock under the Base Case scenario is
6.84
USD.
Compared to the current market price of 28.81 USD,
Septerna Inc
is
Overvalued by 76%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SEPN
Relative Value
Base Case
6.84
USD
Overvaluation 76%
Multiples Across Competitors
SEPN Competitors Multiples
Septerna Inc Competitors
Septerna Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Septerna Inc
NASDAQ:SEPN
|
1.3B USD | 58.1 | -21.8 | -10.7 | -10.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
947B USD | 14.6 | 46.1 | 31.1 | 33.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
268.2B CHF | 4.3 | 20.8 | 12.2 | 13.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.5B GBP | 5.2 | 29.7 | 16.4 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.8B CHF | 5.4 | 21.6 | 13.4 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.5B USD | 4.5 | 16.1 | 10 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.5B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.5B USD | 2.5 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
